New developments in the management of chemotherapy-induced emesis: do they impact on existing guidelines?

Oncology (Williston Park, N.Y.)

Volumn 18, Issue 10 Suppl 6, 2004, Pages 15-19

  Grunberg, Steven M ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; NEUROKININ 1 RECEPTOR;

CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG THERAPY; HEALTH CARE PLANNING; HUMAN; PRACTICE GUIDELINE; REVIEW; VOMITING;

ANTIEMETICS; CLINICAL TRIALS; DRUG THERAPY; HEALTH PLANNING GUIDELINES; HUMANS; PRACTICE GUIDELINES; RECEPTORS, NEUROKININ-1; VOMITING;

EID: 16644388026     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)